COVID - 19疫苗:我们如何做得这么好?

E. Riley
{"title":"COVID - 19疫苗:我们如何做得这么好?","authors":"E. Riley","doi":"10.1002/tre.802","DOIUrl":null,"url":null,"abstract":"Although SARS‐CoV‐2 was relatively easy to design a vaccine against, the speed at which COVID‐19 vaccines have been developed and deployed was surprising. Nevertheless some canny planning along with decades of investment in biomedical research and health informatics, as well as eventually learning from previous disease outbreaks, all helped in the endeavour.","PeriodicalId":425190,"journal":{"name":"Trends - Urology & Men's Health","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID‐19 vaccines: how did we do so well?\",\"authors\":\"E. Riley\",\"doi\":\"10.1002/tre.802\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although SARS‐CoV‐2 was relatively easy to design a vaccine against, the speed at which COVID‐19 vaccines have been developed and deployed was surprising. Nevertheless some canny planning along with decades of investment in biomedical research and health informatics, as well as eventually learning from previous disease outbreaks, all helped in the endeavour.\",\"PeriodicalId\":425190,\"journal\":{\"name\":\"Trends - Urology & Men's Health\",\"volume\":\"47 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends - Urology & Men's Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/tre.802\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends - Urology & Men's Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tre.802","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

虽然针对SARS - CoV - 2的疫苗设计相对容易,但COVID - 19疫苗的开发和部署速度令人惊讶。尽管如此,一些精明的计划以及数十年来在生物医学研究和健康信息学方面的投资,以及最终从以前的疾病爆发中吸取的教训,都有助于这一努力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
COVID‐19 vaccines: how did we do so well?
Although SARS‐CoV‐2 was relatively easy to design a vaccine against, the speed at which COVID‐19 vaccines have been developed and deployed was surprising. Nevertheless some canny planning along with decades of investment in biomedical research and health informatics, as well as eventually learning from previous disease outbreaks, all helped in the endeavour.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信